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ABSTRACT PAGE
In the yeast Saccharomyces cerevisiae, the essential SUMO protease Ulp1 is responsible 
both for removing SUMO/Smt3 (small ubiquitin-like modifier) from specific target proteins 
and for processing precursor SUMO into its conjugation-competent form. Ulp1 localizes 
predominantly to nuclear pore complexes (NPCs) but has also been shown to deconjugate 
sumoylated septins at the bud neck of dividing cells. How Ulp1 is directed to bud-neck 
localized septins and other cytoplasmic deconjugation targets is not well understood. 
Using a structure/function approach, we set out to elucidate features of Ulp1 that are 
required for substrate targeting. To aid our studies, we took advantage of a catalytically 
inactive mutant of Ulp1 that is greatly enriched at the bud-neck of dividing yeast cells. We 
found that the localization of full-length Ulp1 to the bud-neck requires both SUMO and 
specific structural features of Ulp1‘s catalytic domain. In our analysis, we identified a 218 
amino acid-long, substrate-trapping mutant of the catalytic domain of Ulp1, 
Ulp1(3)(C580S), that is necessary and sufficient for bud-neck localization. We used the 
targeting and SUMO-binding properties of Ulp1(3)(C580S) to purify Smt3-modified proteins 
from bacterial and yeast cell extracts. Furthermore, we find that the Ulp1(3)(C580S) 
interacts robustly with monomeric forms human SUM01, SUM02 as well as SUM02 
chains, making it a potentially useful tool for the analysis of sumoylated proteins. In 
summary, our study provides novel insights into how the Ulp1 SUMO protease is actively 
targeted to its substrates in vivo and in vitro.
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INTRODUCTION:
SUMO: A Post-translational modification
The human body consists of approximately 50 trillion cells. There are 
around 200 different types of cells in the body including epithelial cells of the skin, 
neurons in the brain, and contractile muscle cells to name a few. While these 
cells have very different functions in the body, they are all composed of 4 basic 
macromolecules including nucleic acids (DNA and RNA), lipids, carbohydrates 
(sugars), and proteins. Proteins are the drivers of many processes in the cell 
and have roles in metabolism, signaling, and cell structure. The human genome 
project has uncovered that the human genome encodes approximately 25,000 
genes. However, although every cell contains the same genetic material, not 
every cell has the same characteristics and functions. Many differences between 
cells can be traced to differences in protein expression. More importantly, post- 
translational modifications of proteins, for example phosphorylation, acetylation, 
ubiquitination, or sumoylation, are utilized to increase the diversity and function of 
the proteome. Therefore, the total number of potential protein functions is far 
greater than the actual number of proteins encoded inside a cell. Here, we 
explore the functional consequences of SUMO-modification on sub-cellular 
protein targeting during cell division (Fig. 1)
Sumoylation is the attachment of a 98 residue (-14 kDa) protein called 
SUMO (small ubiquitin like modifier). SUMO is a conserved protein that shares 
approximately 18% identity with ubiquitin and both proteins become covalently
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Figure 1. Post-translational modifications increase the functional diversity 
of the cellular proteome.
(A) The human body is composed of 50 trillion cells with each cell containing 
approximately 25,000 genes. (B) Cells are made of 4 basic macromolecules 
including nucleic acids (DNA and RNA), lipids, sugars, and proteins. All cells 
contain the same DNA but express different proteins. Picture from 
http://www.olvmpusfluoview.com. (C) Proteins (red) can be modified by different 
post-translational modifications that can alter the function of the protein and 
increase the diversity of the cellular proteome. These modifications include 
phosphorylation, methylation, acetylation, and sumoylation to name a few. (D) 
Roles of post-translational protein modifications in a cell.
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attached to specific proteins in a reversible manner (Kerscher et al., 2006). 
Ubiquitin is best known for its role in the targeted destruction of proteins including 
key cell-cycle regulators but also holds many non-proteolytic functions (Chen and 
Sun, 2009). Sumoylation, on the other hand, does not directly target proteins for 
proteasomal degradation. Rather, modification of proteins with SUMO has been 
shown to modulate various cellular processes, including cell-cycle regulation, 
transcriptional activation, nucleocytoplasmic transport, DNA replication and 
repair, chromosome dynamics, apoptosis, ribosome biogenesis, and formation of 
nuclear bodies (Wang and Dasso, 2009). These functional distinctions between 
ubiquitin and SUMO have been further blurred by the recent discovery of SUMO- 
targeted Ubiquitin Ligases (STUbLs) that enable SUMO to play an indirect role in 
proteasome-mediated degradation (Perry et al., 2008).
SUMO proteins are highly conserved from yeast to humans. Yeast cells 
express one SUMO protein, Smt3, while vertebrates express three isoforms, 
SUM01, SUM02, and SUM03 (Wilkinson and Henley, 2010). SUM02, SUM03 
and yeast Smt3 can form SUMO chains. SUM01, on the other hand, lacks the 
internal lysine required for polymerization and may function as a chain terminator 
for SUM02 and 3 chains (Matic et al., 2008). SUMO modified proteins contain 
the sumoylation consensus motif T'-K-X-D/E where ^  is a hydrophobic residue 
and X is any amino acid. All SUMO variants are conjugated to lysine residues of 
specific proteins, but only a fraction of these target proteins are modified with 
SUMO at any given time (Hannich et al., 2005; Wykoff and O'shea, 2005).
3
In metazoans, the dysregulation of sumoylation adversely affects 
developmental processes and has been implicated in the progression of 
neurodegeneration, cancer, and infectious diseases (Lamsoul et al., 2005; Sarge 
and Park-Sarge, 2009; Subramaniam et al., 2009). Over a thousand sumoylated 
proteins have been identified in yeast and humans, but only in a few cases has 
the role of sumoylation been studied in detail (Makhnevych et al., 2009). In the 
budding yeast, Saccharomyces cerevisiae, the ligation of SUMO to specific 
substrate proteins requires both an E1 heterodimer (Aos1 and Uba2) to activate 
SUMO, as well as E2 (Ubc9) and E3 (Siz1, Siz2, and Mms21) enzymes to 
catalyze the amide bond formation between the COOH-terminal carboxyl group 
of SUMO and the lysine side chain of acceptor proteins (Kerscher et al., 2006).
SUMO Interacting Motifs
Proteins can interact non-covalently with SUMO modified proteins through 
the use of SUMO interacting motifs (SIMs). SIMs are characterized by a 
hydrophobic core of amino acids (V/l-X-V/l-V/l) flanked by negatively charged 
acidic amino acids (Hannich et al., 2005). Interaction with SUMO requires the 
insertion of SIMs into the hydrophobic core of SUMO (Kerscher, 2007). The 
variability in the composition of the hydrophobic core of SUMO as well as the 
placement of charged amino acids allows SIMs to bind SUMO in either a parallel 
or anti-parallel orientation with respect to the |32 strand of SUMO (Kerscher,
2007). Basic residues of SUMO are proposed to have a role in electrostatic
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interactions with negatively charged residues in SIM-containing proteins (Baba et 
al., 2005; Hecker et al., 2006; Song et al., 2005).
SUMO Proteases
Yeast contain two SUMO proteases while humans utilize six SUMO 
proteases termed sentrin proteases (SENPs) (Mukhopadhyay and Dasso, 2007). 
Yeast proteases are termed ubiquitin-like protease 1 and ubiquitin-like protease 2 
(Ulpl and Ulp2). Ulpl is a 72 kDa protein encoded on the YPL020c open 
reading frame (ORF) on chromosome 16 (Li and Hochstrasser, 1999). Both 
Ulpl and Ulp2 utilize a conserved cysteine protease domain that can remove the 
SUMO moiety from modified proteins. Ulpl has two contrasting cellular 
functions. Ulpl facilitates sumoylation in the context of processing the SUMO 
precursor by removing the amino acid residues ATY. The removal of ATY 
exposes a C-terminal di-glycine motif thus making SUMO competent for 
conjugation. Conversely, Ulpl also facilitates desumoylation by removal of 
SUMO from nuclear and cytosolic proteins after conjugation (Li and 
Hochstrasser, 1999). SUMO deconjugation involves the cleavage of an amide 
bond between the C-terminus of SUMO and the epsilon amine group of the target 
lysine (Kerscher et al., 2006). Therefore, impairment of Ulpl results in the 
accumulation of SUMO conjugates and the inability to carry out de novo 
sumoylation. The resulting lack of mature SUMO has been shown to adversely 
affect cellular DNA repair processes, the processing and nuclear export of the
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60S pre-ribosomal particle, nuclear-cytoplasmic trafficking, and cell viability 
(Lewis et al., 2007; Palancade et al., 2007; Stade et al., 2002; Zhao and Blobel, 
2005). Ulp2, on the other hand, does not contain SUMO processing activity and 
is not an essential gene, but it is required for normal chromosome stability and 
recovery from cell cycle arrest (Kroetz et al., 2009). Recent evidence suggests 
that Ulp2 and its mammalian orthologs Susp1/SENP6 and SENP7 play a role in 
the removal of SUMO and SUMO chains from nuclear proteins (Baldwin et al., 
2009; Bylebyl et al., 2003; Kroetz et al., 2009; Mukhopadhyay et al., 2006; 
Uzunova et al., 2007).
The substrate specificity of SUMO proteases is at least in part regulated 
through their localization (Mukhopadhyay and Dasso, 2007). For example, 
certain yeast (Ulp2) and vertebrate (SENP6 and SENP7) SUMO proteases 
localize within the nucleus. In contrast, both yeast (U lpl) and vertebrate (SENP1 
and SENP2) SUMO proteases reside at the nuclear envelope (NE) through their 
interactions with the NPC (Li and Hochstrasser, 2003; Panse et al., 2003; 
Strunnikov et al., 2001; Zhang et al., 2002). Distinct domains have been 
identified that are required for Ulpl NPC localization (amino acid residues 1-403) 
and SUMO processing (amino acid residues 404-620) (Li and Hochstrasser, 
2003; Makhnevych et al., 2007; Panse et al., 2003; Zhao et al., 2004). The Ulpl 
localization domain promotes interaction with karyopherins, soluble proteins that 
mediate transport across the nuclear envelope, and help localize Ulpl to the
6
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Figure 2. Ulpl amino acid sequence and functional elements.
Ulpl is a 621 amino acid protein that can be divided into 4 functional elements. 
Region 1 comprises residues 1-150 and is the binding site for the importin 
karyopherin 121 (Kap121). Region 2 composes residues 150-340 and is the 
binding site for karyopherin 95 and karyopherin 60 (Kap95-Kap60). Region 2 
also contains a nuclear localization sequence (NLS) that is highlighted in green. 
Ulpl contains a coiled coil domain in residues 341-403 that also may contain a 
putative nuclear export signal (NES). Region 3 composes residues 404-621 and 
is the catalytic domain of the protease. A SUMO-binding surface (SBS) critical 
for U lp l’s interaction with SUMO is highlighted in bold. Aspartic acid residue 451 
(D) that forms a critical salt-bridge interaction with Smt3 is highlighted in yellow. 
The catalytic cysteine (C), residue 580, is highlighted in red. Putative SIMs are 
highlighted in blue italics.
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nucleoplasmic side of the NPC.
The Ulpl localization domain can be subdivided into region 1 (Kap121 
binding domain) and region 2, (Kap60 and Kap95 binding domain) (Fig. 2). 
Juxtaposed to the NPC localization domain of Ulpl is a coiled-coil (cc) domain 
with a putative nuclear export signal, and region 3, the catalytically active, 
conserved ubiquitin-like protease domain (UD) of Ulpl (Li and Hochstrasser, 
2003; Makhnevych et al., 2007; Panse et al., 2003). Only regions 1 and 2 are 
involved in Ulpl localization to the NPC, and karyopherins seem to play a 
redundant role in NPC-anchoring. NPC-association of Ulpl requires several 
proteins, including the nucleoporins Nup60 and Nup84, the silencing protein 
Esc1, and the myosin-like proteins Mlp1/2 (Lewis et al., 2007; Palancade et al., 
2007; Zhao et al., 2004). Together these proteins may provide a scaffold for the 
functional regulation and substrate access of Ulpl at the NPC.
The identification of NPC-localization domains in Ulpl has done little to aid 
our understanding of how SUMO proteases are targeted to their respective 
substrates (Li and Hochstrasser, 2003; Zhang et al., 2002). One possibility is 
that SUMO proteases may contain structural features which allow for non- 
covalent interactions with SUMO and SUMO-modified proteins as they enter the 
nucleus. Indeed, conserved SUMO-interacting motifs, SIMs, have been 
predicted in the yeast SUMO protease Ulp2, as well as mammalian SENP1,2,6, 
and 7 (Kroetz et al., 2009; Matunis et al., 2006; Mukhopadhyay and Dasso, 
2010). Even though SIMs have not been identified in U lpl, the crystal structure
of the catalytic domain (region 3) bound to Smt3 reveals that both proteins 
interact through multiple residues that are distributed across a SUMO-binding 
surface (SBS) on the SUMO protease. Only the carboxy-terminus of bound Smt3 
is inserted into a hydrophobic tunnel that leads towards U lp l’s active site. SUMO 
processing and deconjugation require an active-site cysteine residue that resides 
at the end of this tunnel. It has been suggested that this configuration may allow 
for the accommodation of many different sumoylated proteins, as well as SUMO 
precursors (Mossessova and Lima, 2000).
Ulpl and several other SUMO proteases play important roles in mitosis 
(Dasso, 2008; Li and Hochstrasser, 1999). In budding yeast, loss of Ulp1- 
mediated desumoylation leads to cell cycle progression defects and cell death (Li 
and Hochstrasser, 1999). This observation suggests that Ulpl plays a key role in 
the sumoylation dynamics of important cell cycle regulatory proteins. Though 
these cell cycle-specific targets have eluded identification, several nuclear and 
cytosolic proteins involved in DNA replication and mitosis have been identified as 
Ulpl desumoylation substrates (Leisner et al., 2008; Stelter and Ulrich, 2003; 
Takahashi et al., 2000). How the NPC-localized Ulpl is targeted to these mitotic 
substrates, especially those that are localized in the cytosol, is not entirely clear. 
In budding yeast the nuclear envelope does not break down during mitosis and 
access to cytosolic desumoylation targets is therefore not automatic. It has been 
reported that during mitosis, Kap121 blocks access of Ulpl to its NPC-binding 
site, and thus promotes an interaction of Ulpl with septins (Makhnevych et al.,
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2007). A deletion mutant of Ulpl lacking region 2 (A2), lacking the Kap60 and 
Kap95 binding domain, has previously been shown to localize to septins in a 
Kap121 -dependent manner (Makhnevych et al., 2007). Curiously, it has recently 
been shown that region 2 also plays a role in nucleolar accumulation of Ulpl after 
ethanol-induced stress (Sydorskyy et al., 2010).
Septins
One set of cytosolic substrates of the Ulpl SUMO protease are the septins 
(Makhnevych et al., 2007; Takahashi et al., 2000). The septins in budding yeast 
comprise an evolutionarily conserved class of GTPases that are implicated in 
bud-site selection, bud emergence/growth, microtubule capture, and spindle 
positioning (Spiliotis, 2010). Members of the septin family in yeast include Cdc3, 
Cdc10, Cdc11, Cdc12, and Shs1/Sep7. These proteins are unique because they 
can form filaments that assemble into a ring structure and mark the site of new 
bud formation during cell division. At the end of mitosis, this ring separates and 
resembles a double collar residing at the junction between the mother and 
daughter cells.
The septins Cdc3, Cdc11, and Shs1 are subject to sumoylation. 
Sumoylation of the septins occurs very briefly from the onset of anaphase to 
cytokinesis, with SUMO being attached only to the mother-side of the double 
septin ring collar (Johnson and Blobel, 1999; Makhnevych et al., 2007; 
Takahashi et al., 1999). Cell cycle (G2/M) arrest with nocodazole, a microtubule
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depolymerizing drug, greatly increases SUMO conjugation to septins (Takahashi 
et al., 2000). Septin sumoylation in budding yeast is mediated by the SUMO E3 
ligase Siz1 (Johnson and Gupta, 2001; Takahashi et al., 2001). During most of 
the cell cycle, Siz1 resides in the nucleus. However, at M-phase, Siz1 exits the 
nucleus to sumoylate septin proteins and possibly other cytosolic substrates 
(Takahashi et al., 2008). Deletion of SIZ1 from cells abolishes septin 
sumoylation while causing only mild growth and cell-cycle progression defects. 
At the end of mitosis, the septins are desumoylated by Ulpl even though Ulpl 
remains visibly enriched at the NPC (Johnson and Blobel, 1999; Makhnevych et 
al., 2007; Takahashi et al., 2000). During mitosis, the septins are the most highly 
sumoylated proteins in the cell (Johnson and Blobel, 1999). However, the role of 
septin sumoylation is not well understood. A mutant yeast strain lacking 
sumoylation sites in the septins Cdc3, Cdc11, and Shs1 showed a drastically 
decreased overall level of sumoylation in the cell (Johnson and Blobel, 1999). 
Furthermore, the triple mutant showed improper septin ring disassembly and 
retained unassembled septin rings from previous divisions. However, the triple 
mutant showed no growth defects and no sensitivity to stress conditions (Dasso, 
2008; Johnson and Blobel, 1999). Notably, two other septins, Cdc10 and Cdc12, 
are expressed during vegetative growth and have been shown by proteomic 
analysis to be sumoylation targets (Dasso, 2008). In the triple mutant, it is 
possible that Cdc10 and Cdc12 compensate for the lack of septin sumoylation on 
Cdc3, C dd  1 and Shs1. This idea is supported by the finding that triple mutant is
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synthetically lethal at 25°C in a Cdc12 temperature sensitive strain (Dasso,
2008).
Specific Aims of Thesis
Which mitotic sumoylation targets must be desumoylated to ensure proper 
cell-cycle progression, and how does Ulpl target these proteins? To answer 
these questions, we sought to identify features of Ulpl required for substrate- 
targeting in vivo and in vitro. Here we identify and analyze distinct mutations in 
Ulpl that affect its targeting and retention to sumoylated target proteins at the 
bud-neck of dividing cells. We find that Smt3-interactions comprise an important 
aspect of the sub-cellular targeting of Ulpl to its substrates. Our findings are 
confirmed by biochemical analyses that focus on the SUMO-binding properties of 
Ulpl (3)(C580S) a truncation mutant that interacts avidly with SUMO and 
sumoylated proteins in vivo and in vitro. Significantly, this study adds important 
new details to our understanding how Ulpl interacts dynamically with its 
substrates and also provides potentially useful new directions to the study of 
Ulpl-interacting proteins.
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MATERIALS AND METHODS:
Yeast strains, media and plasmids.
Yeast strains and plasmids used in this study are listed in Table 1. Yeast 
media preparation and manipulation of yeast cells was performed as previously 
published (Guthrie and Fink, 1991). Yeast strains were grown at 30°C unless 
otherwise indicated.
Table 1.
MHY500 Mata his3-A200 leu2- 
3,112 ura3-52 iys2- 
801trp1-1 
gal2
(Li and Hochstrasser, 
2003)
BY4743 MATa leu2A0 met 15AO 
ura3A0
(Winzeler et al., 1999)
YOK
1611
MHY500 ULP1-GFP/LEU2
(BOK454)
This study
YOK
1474
Uj^ p-j(C580S) _
GFP/LEU2
(BOK544)
This study
YOK
1490
u ULP1(Reg1)~ 
GFP/LEU2 
(BOK543)
This study
YOK
1861
u UILP1 (Reg2)~ 
GFP/LEU2 
(BOK 677)
This study
YOK
1479
ULP1(A2)-GFP/LEU2 
(BOK 536)
This study
YOK
2016
ULP1(D451N C580^ -  
GFP/LEU2 
(BOK 667)
This study
YOK “ ULP1(Reg3)~ This study
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1839 GFP/LEU2 
(BOK 633)
YOK
1907
ULP1 (Reg3(C580S) )- 
GFP/LEU2 
(BOK 662)
This study
YOK
1903
ULP1((Reg3ASBS(C58 
0S))-GFP/LEU2 
(BOK 687)
This study
YOK
2203
<< ULP1(SBS)~ 
GFP/LEU2 
(BOK 696)
This study
YOK
1828
ULP1((Reg3(ts))~ 
GFP/LEU2 
(BOK 635)
This study
YOK
2157
u ULP1((Reg3(tsC580S))~ 
GFP/LEU2 
(BOK 776)
This study
YOK
1857
u SMT3-GFP/LEU2 
(BOK 642)
(Panse et al., 2003)
YOK
2204
Cdc3-CFP/L E U2 +
f J I_ p - j ( C 5 8 0 S ) _
GFP/URA3 
(BOK 789 + BOK 738)
(Nishihama et al., 
2009)
YOK
2205
Cdc3-CFP/LE U2 + 
Ulp 1 (Reg3(C580S) )- 
GFP/URA3 
(BOK 789 + BOK 740)
(Nishihama et al., 
2009)
YOK 44 smt3-331 (Biggins et al., 2001)
YOK
1995
U I _ p - j ( C 5 8 0 S ) _
GFP/LEU2 
(BOK 544)
This study
YOK 847 ubc9-1 (Betting and Seufert, 
1996)
YOK
2065
ULP1(C580S)- 
GFP/URA3 
(BOK 738)
This study
YOK
2144
u SMT3-GFP/URA3 
(BOK 658)
This study
GBY1 MATa smt3 
R11,15,19..TRP1
(Bylebyl et al., 2003)
YOK
1910
GBY1 [ J j_ p - f ( C 5 8 0 S )  _
GFP/LEU2 
(BOK 544)
This study
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yDS880 MA 7a-inc ade2-101 his3- 
200 Ieu2-1:: GAL-HO- 
LEU2 Iys2-801 
RAD53::FLAG-HIS3 
sizV/.NAT 
siz2:: HPH sml 1:: KAN 
trp1-63 ura3-52 VII- 
L::TRP-HO site-LYS2
(Schwartz et al., 2007)
YOK
2067
UI_P1(C580S)- 
GFP/URA3 
(BOK 738)
This study
YOK
2143
SMT3-GFP/URA3 
(BOK 658)
This study
kap121ts kap121::ura3::HIS3 ura3- 
52 his3A200 trp1-1 Ieu2- 
3,112 Iys2-801
pRS314-kap 121 -34 (Leslie et al., 2002)
YOK
1487
kap121ts ULP1-GFP/LEU2 
(BOK 454)
This study
YOK
1488
kap121ts p  j  (C580S) _
GFP/LEU2 
(BOK 544)
This study
YOK
1944
kap121ts ULP1(Reg3(C580S) )- 
GFP/LEU2 
(BOK 662)
This study
AH 109 MATa, trp 1-901, leu2-3, 
112, ura3-52, his3- 
200,gal4A, gal80A,
L YS2::GAL 1UAS- 
GAL1TATA- 
HIS3, GAL2UAS- 
GAL2TATA-ADE2, 
URA3::MEL 1UASMEL1T 
ATA-lacZ, MEL1
Clontech, CA 
Cat. # 630444
YOK
2173
AH109 ULP1 (Reg3(C580S))- 
pOAD/LEU2 + SMT3- 
pOBD/TRPI 
(BOK 641 + BOK 295)
This study
YOK
2175
AH 109 ULP1 (Reg3(D451N})- 
pOAD/LEU2 + SMT3- 
pOBD/TRP1 
(BOK 796 + BOK 295)
This study
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YOK
2177
AH 109 ULP1 (Reg3(ts))~ 
pOAD/LEU2 + SMT3- 
pOBD/TRP1 
(BOK 645 + BOK 295)
This study
YOK
2181
AH109 ULP1 (Reg3(tsC580S))- 
pOAD/LEU2 + SMT3- 
pOBDfTRPI 
(BOK 775 + BOK 295)
This study
YOK
2212
AH 109 ULP1 (Reg3(D451N 
C580S))-pOAD/LEU2 + 
SMT3-pOBD/TRP1 
(BOK 799 + BOK 295
This study
YOK
2183
AH 109 SMT3-pOAD/LEU2 + 
SLX5 pOBD/TRP1 
(BOK 295 + BOK 289)
This study
YOK
2185
AH 109 vector-pOAD/LEU2 + 
vector pOBD/TRP1 
(BOK 312 + BOK 313)
This study
YOK 428 ulp1::KAN (segregant of 
heterozygous diploid 
ULP1 /ulp 1 ::KAN in 
BY4743 - 
( OpenBiosystems, 
Huntsville, A L  -  Cat.# 
YSC1021-671376)
ulp 1 ts/TRP/NA T 
GPD-FLAG- 
SMT3gg/pRS425
This study
YOK
1398
Wildtype (YOK 
821 xnup 170A::G418 
CDC3-YFP/HIS5)
This study
DNA fragments containing Ulpl under the control of its endogenous promotor 
were amplified from yeast genomic DNA and placed in-frame with a carboxy- 
terminal GFP tag in the CEN/LEU2 plasmid pAA3 (Sesaki and Jensen, 1999). 
Primer pairs used for full-length Ulpl amplification were OOK2 (ULP1 (-310 to - 
294)) and OOK3 (ULP1 (+1842 to +1863)). To prepare truncated and mutated 
Ulp1-GFP constructs listed in Table 1, Quikchange XL Site-Directed Mutagenesis
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(Stratagene) and Phusion Site-Directed Mutagenesis kits (Finnzyme) were used 
according to manufacturer’s instruction. Primer sequence information for the 
construction of individual mutants and truncations are available upon request. All 
constructs were sequenced verified. Additionally, activity of tagged Ulpl 
constructs was confirmed in complementation assays. For two-hybrid constructs, 
ORFs of the indicated genes were PCR-amplified and homologously recombined 
into gapped pOAD and pOBD2 vectors (Yeast Resource Center, WA). To 
overexpress and purify Ulpl truncations from bacteria, the respective Ulpl 
fragments were PCR-amplified and cloned into pMALc-HT (a gift from Sean 
Prigge, JHSOM), thereby adding an in-frame maltose-binding protein (MBP) 
module followed by a TEV protease cleavage site and a His6 epitope tag. Ulpl 
derivatives were expressed as MBP fusions in BL21 Star (DE3) cells containing a 
pRIL plasmid expressing several rare-codon tRNAs (a gift from Sean Prigge, 
JHSOM, MD). Cdc3-CFP/LEU2 plasmid YCp-111 (BOK 789) was a kind gift 
from Ryuichi Nishihama in John Pringle’s lab.
Yeast Two-Hvbrid Assays
Gal4-Activation-domain (AD) fusions of ULP1 and the indicated ULP1 
mutants in pOAD were transformed into the AH 109 reporter strain expressing a 
Gal4-DNA-binding-domain (BD) fusion of SMT3 in pOBD. Two-hybrid 
interactions were scored by streaking on dropout media lacking adenine.
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Pulldown assays, affinity purification, and protein extracts:
Frozen bacterial cell pellets from 200ml of IPTG-induced BL21 Star (DE3) 
cells were thawed on ice and resuspended in 2ml 1x phosphate buffered saline 
(PBS) containing 1x Halt Protease Inhibitor Cocktail (Pierce Cat. # 78430). Ice- 
cold cells were sonicated using a Branson Sonifier and extracts were cleared by 
centrifugation at 15kRPM (21,000 RCF) for 8 minutes at 4°C. Cleared bacterial 
extracts were added to 15 mL conical tubes and diluted using 4ml 1x PBS 
containing the protease inhibitor cocktail. MBP-tagged proteins (MBP-Ulp1(3), 
Ulpl (3)(C580S) or Ulpl (3)(C580S)ASBS) were bound to 5ml columns containing 
300/ul amylose resin (New England Biolabs) and washed extensively with 1x 
PBS. Whole yeast cell extracts containing the indicated target proteins were 
passed over the amylose resin and proteins bound to MBP-Ulp1(3), 
Ulpl (3)(C580S) or Ulpl (3)(C580S)ASBS were eluted with 100mM maltose or SDS- 
PAGE sample buffer. For SUMO pulldown experiments, recombinant MBP- 
Ulp1 (3)(C580S) or MBP-Ulp1 (3) was incubated with SUMO-1 or SUMO-2 agarose 
(Boston Biochem) in 1 ml of 1xPBS with protease inhibitors (Thermo Scientific). 
Proteins bound to the agarose beads were washed in 1xPBS and eluted with 1x 
SDS-PAGE sample buffer. All protein extracts were run out on NOVEX 4-12% 
BIS-TRIS gradient gels (invitrogen #NP0321) using MOPS-SDS running buffer 
(Invitrogen #NP0001).
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Fluorescent Microscopy
Unless otherwise noted, cells were grown in rich media, G2/M arrested 
using nocodazole (15 /vg/ml/3h/30°C), washed in 2% dextrose, and harvested by 
centrifugation. Images of live cells were collected using a Zeiss Axioskop fitted 
with a Retiga SRV camera (Q-imaging), i-Vision software (BioVision 
Technologies), and a Uniblitz shutter assembly (Rochester, NY). Pertinent filter 
sets for the above applications include CZ909 (GFP), XF114-2 (CFP), XF104-2 
(YFP) (Chroma Technology Group). Images were normalized using i-Vision 
software and pseudo-colored and adjusted using Adobe Photoshop software 
(Adobe Systems Inc.).
In vitro ubiquitvlation reactions, recombinant proteins, and antibodies:
In vitro ubiquitylation assay -  enzymes and substrates used in our in vitro 
ubiquitylation assays were quantified using a Protein 230 kit on the Agilent 2100 
Bioanalyzer according to the manufacturer’s instructions. 10x ubiquitylation 
buffer, E1 enzyme (Uba1), ATP, and 20x ubiquitin were provided in a commercial 
ubiquitylation kit (Enzo # BML-UW0400). Ubiquitylation buffer, IPP (100 U/ml), 
DTT (50 pM), E1 (Uba1), E2 (Ubc4), and E3 enzymes (RNF4) were combined 
with purified SUM02 chains (#ULC-210 -- Boston Biochem, MA) and ubiquitin. 
Reactions totaled 27 pL and were incubated at 30°C for three hours. Reactions 
were stopped by adding an equal volume of SUTEB sample buffer (0.01% 
bromophenol blue, 10 mM EDTA, 1% SDS, 50 mM Tris at pH 6.8, 8 M Urea)
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containing DTT (5 pL of 1 M DTT/1 mL SUTEB sample buffer). Protein products 
were boiled in a 65°C heat block for ten minutes and analyzed by western blot 
with anti human SUMO-2 antibody. Anti-human SUM02 # BML-PW0510-0025 
(ENZO Life sciences, PA), anti-GFP: JL8 # 632380 (Clontech, CA), anti-
FLAG(M2) #F3165 (Sigma-Aldrich, MO), anti-PGK: 22C5 # 459250 (Invitrogen, 
CA).
Measurement of Ulp1 3(C580S)-SUMO-1 binding affinity using surface plasmon 
resonance:
Affinity constants of Ulp1 3(C580S) and SUMO-1 were determined by Affina 
Biotechnologies (Stamford CT) using a Biacore 3000 instrument. Biotinylated 
SUMO-1 (Boston Biochem., Cat# UL-725) was immobilized on research grade 
streptavidin-coated sensor chips (Sensor Chip SA, Biacore Inc.) that were 
pretreated according to the manufacturers instructions. MBP-Ulp1 3(C580S) was 
injected at a flow rate of 20 jil/min in 20 mM sodium phosphate, 150 mM NaCI, 
0.05% P-20, 1 mg/ml BSA, pH 7.4 (running buffer) for 3 min. Equilibrium binding 
data of MBP-Ulp1 3(C580S)-SUMO-1 were calculated using the BIAevaluation 
software (Biacore Inc.).
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RESULTS:
Ulp1 localization to the nuclear envelope and the septin ring.
As part of a larger study to identify how Ulp1 is targeted to its mitotic 
desumoylation substrates, we analyzed the localization of green fluorescent 
protein (GFP)-tagged versions of both the full-length wildtype Ulp1 (WT) and a 
catalytically inactive mutant of Ulp1 (Ulp1(C580S)) in G2/M-arrested yeast cells. 
The C580S mutation replaces the catalytic cysteine with a serine residue, 
rendering the Ulp1 SUMO protease catalytically inactive (Li and Hochstrasser, 
1999). Both fusion proteins were expressed under the control of the Ulp1 
promotor on low-copy plasmids, and images were collected using a fluorescent 
microscope. Consistent with its localization to nuclear pore complexes, wildtype 
Ulp1 only stained the nuclear envelope of arrested yeast cells (Fig. 3 A - left). 
Unexpectedly, however, full-length Ulp1(C580S) was enriched both at the bud-neck 
and the nuclear envelope of G2/M arrested cells (Fig. 3 A - right). This bud-neck 
localization of full-length Ulp1 is reminiscent of the localization of the septin ring. 
Several sumoylated septins have been shown to be Ulp1 substrates and we 
show that the septin Cdc3 is higly sumoylated during G2/M arrest (Fig 3B). 
Indeed we found that the localization of Ulp1(C580S) at the bud-neck corresponds 
to the position of the septin ring (Fig 3C -  bottom). Specifically, cyan fluorescent 
protein (CFP)-tagged septin, Cdc3-CFP, colocalized with Ulp1(C580S) when septins 
were sumoylated during G2/M arrest (noc) (Fig. 3C). Therefore, Ulp1(C580S) 
resides at the bud-neck localized septin ring.
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Figure 3. Localization of Ulp1 and the catalytically inactive Ulp1(C580S) in 
dividing yeast cells. (A) Upper panel: Yeast cells (MHY500) were transformed 
either with a low-copy plasmid expressing GFP fusions of Ulp1 or the catalytically 
inactive Ulp1(C580S) mutant. Shown are representative images indicating the 
localization of GFP-tagged Ulp1 and Ulp1(C580S) after nocodazole-induced G2/M 
arrest (YOK 1611 and YOK 1474). Note that only the Ulp1 (C580S> mutant can be 
visualized at the bud-neck of arrested cells. The arrowhead denotes the position 
of the bud-neck. (B) Confirmation of sumoylation of Cdc3. Whole cell extracts 
(WCEs) from yeast cells expressing the YFP-tagged septin Cdc3 (YOK 1398) 
were treated with nocodazole (noc) or grown logarithmically (log) prior to 
preparation of whole cell extracts. Extracted proteins were then separated on 
SDS-PAGE gels and probed with the JL-8 antibody (see materials and methods) 
to detect Cdc3-YFP and slower migrating sumoylated Cdc3-YFP adducts. 
Identity of sumoylated Cdc3-YFP bands was confirmed by comparing gel-shift 
assays with untagged and FLAG-tagged Smt3 (data not shown). (C) 
Colocalization of Cdc3 and Ulp1. A strain coexpressing full-length uip1(C580S)- 
GFP (green) and Cdc3-CFP (red) (strain YOK 2204) was arrested in G2/M and 
then observed using a fluorescence microscope with the appropriate filter sets 
(left panel). Indicated (arrow heads) are septin-localized pseudo-colored Ulp1- 
GFP (green) and Cdc3-CFP (red) and the merged image (overlay). Also shown, 
for comparison (right panel), is the colocalization of the Ulp1(3)(C580S)-GFP 
truncation and Cdc3-CFP (strain YOK 2205). Ulp1(3)(C580S)-GFP is further 
described in Fig. 5.
Our data suggest that introducing the C580S mutation into the catalytic 
domain of Ulp1 somehow alters the subcellular distribution of this SUMO 
protease mutant to associate with a bud-neck associated substrate, possibly a 
sumoylated septin protein. Localization changes have also been reported for 
catalytically inactive, substrate-trapping mutants of phosphatases that form 
stable complexes with their substrates in vivo (Flint et al., 1997).
SUMO is required for Ulp1 localization to the septin-ring.
Next, we tested whether the C580S mutation that visually increased the 
ability of full-length Ulp1 to associate with the septin ring in vivo was, in fact,
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SUMO-dependent. For this purpose, the Ulp1 <C580S) construct was expressed in 
two Smt3 mutants (smt3-331 and smt3-R11,15,19) or two SUMO pathway 
mutants (ubc9-1, s izIA  siz2A) (Betting and Seufert, 1996; Biggins et al., 2001; 
Bylebyl et al., 2003; Schwartz et al., 2007; Takahashi et al., 1999; Takahashi et 
al., 2001). Logarithmically growing cells of each mutant were arrested in G2/M, 
and images were collected to assess the septin ring localization of Ulp1(C580S) in 
comparison to a SMT3 wildtype strain. In our analyses, we found that in both the 
absence of SUMO chains (in the R11,15,19 mutant) and improperly formed 
SUMO chains (in the smt3-331 mutant), the localization of Ulp1(C580S) to the 
septin ring was reduced but not abolished (Fig. 4A). However, we obtained 
different results in the ubc9-1 strain, a mutant of the SUMO E2 conjugating 
enzyme which impairs SUMO conjugation, and the sizIA  siz2A strain, a SUMO 
E3 ligase double mutant that lacks sumoylation of septins and many other 
proteins (Betting and Seufert, 1996; Johnson and Gupta, 2001; Takahashi et al., 
2001). Consistent with a role for Smt3 in the localization of Ulp1(C580S), we were 
unable to detect septin ring localization of Ulp1(G580S) in ubc9-1 and sizIA  siz2A 
strains. However, Ulp1(C580S) was retained at the nuclear envelope (Fig. 4A). As 
an additional control, the septin ring localization of GFP-tagged Smt3 was 
undetectable in both ubc9-1 and siz1Asiz2A strains (Fig. 4B).
In summary, Smt3 is required for Ulp1 localization to the bud-neck that 
comprises the septin ring. Therefore, Ulp1 is targeted to the septin ring of 
dividing cells in a SUMO-dependent fashion. Our data also suggest that the
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Figure 4. SUMO is required for the localization of Ulp1(C580S) to the septin 
ring. (A) The indicated mutants (smt3-331, ubc9-1, smt3-R11,15,19, siz1Asiz2A) 
and a wildtype control strain (WT) were transformed with a plasmid expressing 
GFP-tagged Ulp1(C580S). Shown are representative images indicating the 
localization of GFP-tagged Ulp1(C580S) after G2/M arrest. The septin ring 
localization of Ulp1(C580S) is indicated when present (arrowheads). Note that 
Ulp1(C580S) fails to localize to the septins in SUMO-conjugating and -ligating 
enzyme mutants (ubc9-1 and sizIA  siz2A, respectively). (B) Septin localization of 
Smt3-GFP is absent in ubc9-1 and s izIA  siz2A strains. Localization of SUMO- 
GFP was visualized in G2/M-arrested wildtype (WT), ubc9-1, and sizIA  siz2A 
strains using fluorescence microscopy. Position of the septin ring is indicated 
(arrow heads).
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formation of SUMO chains on substrates may enhance this targeting of Ulp1
Distinct and separate Ulp1 domains are required for localization to the 
septin ring.
Our finding that a single point mutation in Ulp1, C580S, dramatically 
enhanced the localization of full-length Ulp1 to the septin ring in a SUMO- 
dependent fashion warranted a more detailed analysis of the targeting domains 
in Ulp1. Therefore, we generated a collection of GFP-tagged Ulp1 truncations 
and domains that were expressed under control of the Ulp1 promotor. We 
reasoned that the truncations and domains of Ulp1 that retained substrate- 
targeting information would also localize to the septin ring in G2/M-arrested cells. 
In all, we assessed the localization of ten GFP-tagged constructs in comparison 
to full-length wildtype Ulp1 (WT) and full-length Ulp1(C580S) (C580S). Our choice 
of individual constructs was guided by previous findings that Ulp1 consists of 
functionally separate domains. These domains include a Kap121-binding domain 
with a role in septin localization (region 1), a Kap95-Kap60-binding domain with a 
role in NPC anchoring (region 2), a coiled-coil domain harboring a nuclear export 
signal (CC), and the catalytic UD domain (region 3) (Li and Flochstrasser, 2003; 
Makhnevych et al., 2007; Panse et al., 2003). Representative images of these 
domains and their subcellular localizations are shown in Figure 5A and B. As 
previously reported, we found that the Ulp1 protein lacking region 2, (A2), 
localized to the septin ring in the majority of large-budded, arrested cells
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(Makhnevych et al., 2007). Therefore, region 2 of Ulp1 normally antagonizes 
localization and/or retention at the septin ring. This result is complemented by 
our novel finding that the full-length Ulp1(C580S) localized to the septin ring in 31% 
of all arrested, large-budded cells (n>100) (Fig 3A and 5A).
Next, we investigated other residues of Ulp1 that could affect the septin ring 
localization of the Ulp1(C580S) mutant, possibly by interfering with its targeting to 
sumoylated substrates. Aspartate 451 (D451) in Ulp1 is required to form an 
essential salt-bridge with arginine 64 of Smt3 (lhara et al., 2007; Mossessova 
and Lima, 2000). Therefore, we introduced a D451N mutation into Ulp1(C580S) 
and found that it abolished the accumulation of the full-length Ulp1 double mutant 
(D451N, C580S) at the septin ring (Fig. 5A). This finding underscores the 
importance of Smt3 in targeting full length Ulp1 to the septin ring shown in Figure 
4. Additionally, it may indicate that aspartate 451 is required for targeting of 
sumoylated proteins while the C580S mutation is required for retention of Ulp1 at 
the septin ring.
Most intriguingly, we found that a truncation consisting only of region 3 with 
the C580S mutation (Ulp1(3)(C580S)), displayed septin ring localization in 59% of 
cells (Fig 3C (right panel) and Fig 5B). In stark contrast, regions 1, 2, and 
wildtype region 3, lacking the C580S mutation, failed to localize to the septin ring 
(Fig. 5A and B). However, where Ulp1 is displaced, the septin ring stays intact 
(data not shown). Therefore, necessary and sufficient SUMO-dependent 
targeting information is contained in region 3 of Ulp1 but not region 1 and 2. The
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Figure 5. Distinct and separate Ulp1 domains are required for localization 
to the septin ring. (A and B) Left: Schematic representation of Ulp1 deletion and 
truncation mutants used in this study. The length of each construct (amino acid 
scale: 1-621), individual domains of Ulp1, and pertinent amino acid changes are 
shown. WT: full-length Ulp1, region 1: Ulp1 (1-150) , region 2: Ulp1 (151 -340), 
region 3: Ulp1 (341 -621), A2: Ulp1 lacking region 2, C580S: catalytically 
inactivating mutation, D451N: deleted salt-bridge with SUMO. Colored letters N, 
S, D summarize the observed nuclear, septin or diffuse localization of the 
indicated constructs, respectively. SBS corresponds to a shallow SUMO-binding 
surface on Ulp1 (28,51,52). Right: Representative images of G2/M arrested cells 
expressing the GFP-tagged Ulp1 constructs shown on the left. The fraction of 
cells (%) with nuclear, septin or diffuse localization and the presence and position 
of bud-neck localized Ulp1 constructs is indicated (arrow heads). (C) 
Quantification of distinct subcellular localization of wildtype and mutant Ulp1 
region 3 constructs. Large-budded G2/M arrested cells were imaged to assess 
either diffuse, nuclear, or bud-neck localization (n>100).
latter conclusion is also confirmed by two-hybrid assays with Smt3 (Fig. 9).
The previously published co-crystal structure of Ulp1 with Smt3 (MMDB 
database # 13315) reveals that amino acids 418-447 of region 3 make extensive 
contact with Smt3 and constitute an exposed SUMO-binding surface (SBS - see 
also Fig. 6) (Mossessova and Lima, 2000). The SBS is situated next to, but does 
not include, the critical D451 residue that contacts Smt3 (lhara et al., 2007). 
Additionally, deletion of this SBS in region 3 of Ulp1 abolishes the 
complementation of a ulp lA  deletion mutant (Li and Hochstrasser, 2003). In an 
attempt to identify critical residues in the evolutionary conserved SBS domain, we 
used psi-blast to compare the protein sequence of the yeast Ulp1 catalytic 
domain to all non-redundant protein sequences in the NCBI database for seven 
iterations and limited the output to the top 250 matches. While there was an 
obvious bias toward model organisms for which more sequences were available,
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our results contained 81 different species; 61% of the sequences were identified 
as verified or predicted sentrin/SUMO protease/Ulpl genes, 24% were identified 
as unnamed protein products or hypothetical genes and 15% were “other” 
(crystal structures, unanalyzed sequence, etc.). The alignment of these 
sequences allowed us to identify areas of strong conservation (see figure 7A and 
7B). Using this approach we identified several highly conserved residues in the 
SBS. However, these amino-acids did not contact Smt3 in the published co­
crystal structure and likely play structural roles in Ulp1 folding (Mossessova and 
Lima, 2000).
Smt3
U!p1 (3)
Figure 6. 3D co-crystal structure of Ulp1 Reg 3 and Smt3. Three dimensional 
representation of the co-crystal structure of the catalytic domain of Ulp1 (Ulp1(3) 
-- magenta) with yeast SUMO (Smt3 -- blue). Indicated in yellow and labeled 
with the appropriate amino acids are N450, D451, and C580. Also shown is the 
SUMO-binding surface (SBS).
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We also investigated the effect of deleting the entire SBS domain on the 
localization of Ulp1(3){C580S). A Ulp1 (3)(C580S)ASBS construct does not localize to 
the septin ring in the majority of cells (96%). The results match those obtained 
by Li and Hochstrasser using a wildtype Ulp1(3)ASBS construct (C173) (Li and 
Hochstrasser, 2003). We also cloned and expressed the SBS domain as a 
fusion with the green fluorescent protein (SBS-GFP). This construct distributed 
diffusely throughout the cell and failed to localize to the septin ring (Fig. 5 
middle). These data suggest that the SBS domain of region 3 may be required 
for the initial interaction with sumoylated substrates but additional features of 
Ulp1 are required for targeting (D451) and retention (C580S) of this SUMO 
protease at the septins.
Next, we directed our attention to the temperature-sensitive ulp1ts-333 
allele. This mutant allele causes cells to arrest in mitosis and accumulate 
unprocessed SUMO precursor and sumoylated proteins (Li and Hochstrasser, 
1999). Our u lp lts  construct of region 3, Ulp1(3)ts, contains three mutations 
(I435V, N450S, I504T), and introduction of C580S into Ulp1(3)ts showed a greatly 
reduced incident and intensity of septin ring localization (compare panels in Fig. 
5B and 5C). We noted that the (N450S) mutation in the ts construct was located 
next to the salt-bridge forming residue D451 described above and that both 
residues are highly conserved in the consensus sequence of Ulp1 -like molecules 
(Fig. 7A and 7B). This suggested that residues altered in ulp1ts-333, specifically 
N450, may contribute to Smt3 interaction and possibly substrate targeting. It is
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Figure 7. Identification of important features required for Ulp1 targeting 
and SUMO-binding. (A) The yeast Ulp1 catalytic domain was blasted against all 
non-redundant protein sequences in the NCBI database using psi-blast. After 7 
iterations, the top 100 query sequences (only 11 are shown) were aligned, which 
included a variety of animal, plant and fungal species. Shown in red are residues 
that constitute the SUMO-binding surface (SBS). Also indicated are the salt- 
bridge forming D451 and one of the residues mutated in the u lp lts  allele, N450. 
Conservation: conservation of amino acid properties. Quality', alignment quality 
based on Blosum 62 scores; high values suggest no or conservative mutations. 
Consensus: percent identity. Calculated using Jalview. (B): Consensus SBS 
based on the alignment of 250 sequences from 81 species. The height of the 
letters corresponds to the frequency of the amino acid in the alignment; width is 
based on the proportion of sequences that contain a character (many gaps lead 
to narrow letters). Also indicated are the salt-bridge forming D451 and one of the 
residues mutated in the u lp lts  allele, N450 (weblogo.threeplusone.com)(Crooks 
et al., 2004).
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possible that N450S perturbs the salt-bridge interaction formed between D451 of 
Ulp1 and R64 of Smt3 therefore reducing the interaction with Smt3 and 
contributing to the temperature sensitive phenotype. In support of this, correction 
of the N450S mutation in Ulp1(3)ts (S450N) partially rescued the slow growth defect 
of a ulp lA  strain at 30° and 37°C (data not shown). The effect of the ulp lts 
mutation on Ulp1 ’s ability to interact with Smt3 is explored in more detail below 
(Fig. 9).
In conclusion we find that several features, most importantly D451 and 
C580S, in region 3 of Ulp1, beyond the previously identified SBS domain, are 
required for targeting and retention at the septin ring (see Fig. 5, 6 and 7).
Kap121-independent SUMO-targeting information resides in Ulp1(3)(C580S).
Above, we describe our identification of necessary and sufficient substrate- 
targeting information in the catalytic domain (region 3) of Ulp1. However, region 
3 of Ulp1 may not be the only domain involved in targeting to the septins. Region 
1 of Ulp1, the Kap121-binding domain, has previously been implicated in septin- 
targeting. Specifically, it has been reported that Kap121 is required for targeting 
Ulp1 to the septin ring during mitosis (Makhnevych et al., 2007). Therefore, we 
decided to assess the role of Kap121 in the substrate-targeting of Ulp1 (3){C580S). 
Specifically, we used a kap121ts mutant (Leslie et al., 2002) to assess the septin 
ring targeting of wildtype Ulp1, full-length Ulp1(C580S), and Ulp1(3)(C580S). In our 
analysis, we found that full-length Ulp1(C580S) required Kap121 function for
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targeting to the septin ring. At the permissive temperature (30°C), Ulp1(C580S) 
demarcated the nuclear envelope and septin ring of G2/M arrested cells. After a 
shift to the non-permissive temperature, however, Ulp1(C580S) could no longer be 
detected at the septin ring (Fig. 8 - middle panel). Surprisingly, Ulp1(3)(C580S), 
was localized to the bud-neck at the permissive and non-permissive temperature 
for kap121ts. As shown here at 30°C and 37°C, Ulp1 (3)<C580S> resided both inside 
the nucleus and at the septin ring (Fig. 8 - right panel).
Figure 8. Kap121-independent SUMO-targeting information resides in 
region 3 of Ulp1 (A) kap121ts cells were transformed with plasmids expressing 
GFP-tagged wildtype (WT) Ulp1, uip1(C580S), and Ulp1(3)(C580S) under the control 
of the Ulp1 promotor. Shown are representative images indicating the localization 
of GFP-tagged Ulp1 constructs in large-budded cells at 30°C and 37°C, the non- 
permissive temperature for kap121-ts. The position of bud-neck localized Ulp1 
constructs is indicated (arrowheads).
Our data suggest that Ulp1 contains both Kap121-dependent and 
independent bud-neck targeting information. The only requirement to detect full-
GFP: Ulp1 (WT) Ulp1<C580S> Ulp1 (3)(C580S>
37°C
30°C
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length Ulp1 and Ulp1(3) at the bud-neck is the C580S mutation and functional 
Kap121 (Fig. 3, 4, 5, and 8). In contrast Ulp1(3)(C580S), which lacks all domains 
required for NPC interaction through Kap121, Kap60, and Kap95, localizes to the 
budneck and inside the nucleus. In summary, this finding provides strong 
evidence that Kap121-independent bud-neck-targeting information resides in the 
catalytic domain (region 3) of Ulp1.
Multiple features in the catalytic domain of Ulp1 affect SUMO interactions.
Our finding that a single amino-acid change in the catalytic domain of Ulp1 
results in greatly enhanced, SUMO-dependent localization to the bud-neck also 
prompted us to investigate the two-hybrid interactions of Ulp1(3)(C580S) with 
budding yeast SUMO (Smt3-BD). Full-length wildtype Ulp1, the full-length 
catalytically inactive Ulp1(C580S) mutant, the Ulp1 Kap121-interacting domain 
(region 1), the Ulp1 Kap60/Kap95-interacting domain (region 2), and the catalytic 
domain (region 3) all failed to interact with Smt3 fused to the Gal4 DNA-binding 
domain (data not shown). However, the catalytically inactive Ulp1 (3)(C580S) 
truncation interacted weakly, but reproducibly and above background, with Smt3 
(see Fig. 9)
Next, we focused on the important residues near the SBS domain of Ulp1 
region 3 (see Fig. 5B and 6). First, we investigated the D451N mutant of Ulp1 
that prevents the interaction of Ulp1 with SUMO (lhara et al., 2007; Mossessova 
and Lima, 2000)
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Figure 9. Distinct and separate Ulpl domains are required for interaction 
with SUMO. (A) Two-hybrid analysis of various Ulp1 region 3 truncations with 
SUMO (C580S: catalytically inactive; D451N: deleted salt-bridge with SUMO; ts: 
mutations including S450N in ulp1ts-333). The presence of both Smt3 
(pOBD2/TRP1) and Ulp1 constructs (pOAD/LEU2) was confirmed by growth on 
medium lacking tryptophan and leucine (-T-L). The interaction between Ulp1 
constructs and Smt3 is shown as duplicate streaks on media lacking adenine (- 
A). See Fig. 5A and B for a graphic representation of individual constructs
As shown above, D451N, when introduced into Ulp1(C580S), prevented 
localization to the septin ring (Fig 5A). Accordingly, we found that introduction of 
the D451N mutation into Ulp1(3)(C580S) destroyed its interaction with Smt3 (see 
Fig. 9). We reasoned that Ulp1(3)(C580S) alone fails to score strongly with Smt3 
because it is avidly interacting with free Smt3 or is sequestered by sumoylated 
proteins in the cell and, therefore, failed to interact with the BD-Smt3 fusion. We 
therefore proposed that weakening of the interaction between Ulp1 (3)(C580S) and 
Smt3 could allow for a two-hybrid interaction to be scored. In support of this 
hypothesis, we found that introducing the u lp lts  mutations in the Ulp1 (3)(C580S) 
construct, forming Ulp1(3)ts (C580S), also enhanced interaction with Smt3. These 
observations provide evidence that the targeting of Ulp1 to sumoylated 
substrates is a closely balanced act involving both Smt3 targeting and retention.
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The Ulp1(3)(C580S) truncation binds SUMO and SUMO-modified proteins.
We hypothesized that if Ulp1(3)(C580S) were to interact avidly with Smt3, this 
mutated moiety of Ulp1 could efficiently interact with SUMO adducts in vitro. 
Therefore, to test the direct interaction of Ulp1(3)(C580S) with SUMO, we fused this 
domain to the carboxy-terminus of the maltose binding protein (MBP) and 
expressed large amounts of the recombinant fusion protein in bacteria. 
Subsequently, the MBP-Ulp1(3)(C580S) fusion protein was purified from bacterial 
extracts and bound to amylose resin. As a control to assess the ability of the 
MBP-Ulp1(3)(C580S) to interact with sumoylated proteins, we also purified a 
second MBP-fused Ulp1 (3)(C580S) construct lacking the SBS domain 
(3(C580S)ASBS).
First, we determined the ability of MBP-Ulp1 (3)(C580S) to affinity-purify 
sumoylated proteins from crude yeast cell extracts. ulp1ts-333 cells expressing 
FLAG-tagged-SMT3 (YOK428) were grown to log-phase prior to preparation of 
yeast cell extracts (see material and methods). These extracts were then 
incubated with resin-bound MBP-Ulp1(3)(C580S), MBP-Ulp1(3)(C580S)-ASBS, or 
unbound amylose resin. After washing, bound yeast proteins were eluted, 
separated on SDS-PAGE gels, and analyzed by western blotting with an anti- 
FLAG antibody. Flag-SMT3-modified proteins present in the whole cell extracts 
(WCE) (Fig. 10A lane 2) could clearly be detected bound to MBP-Ulp1(3)(C580S) 
(lane 5) but not the MBP-Ulp1(3)(C580S)-ASBS control protein (lane 4). We 
identified both unconjugated Flag-Smt3 protein as well as several higher
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molecular weight adducts. These data suggest that Ulp1 (3)<C580S) can efficiently 
bind and enrich sumoylated proteins from crude yeast cell extracts. To 
demonstrate the versatility of Ulp1(3)(C580S) -aided Smt3 purification, we also 
purified monomeric and conjugated GFP-Smt3 from yeast cells (Fig. 10B). 
Additionally, we probed extracts and eluted proteins shown in figure 10B with an 
anti Cdc11 antibody, revealing the specific co-purification of Cdc11 with 
immobilized Ulp1 (3)(C580S) (Fig. 10C).
In the reciprocal experiment, we tested whether a GFP-tagged Ulp1(3)(C580S) 
construct expressed in yeast cells could bind immobilized SUM02 which is highly 
conserved to yeast Smt3. In this experiment, yeast cells expressing CEN- 
plasmid levels of the GFP-tagged Ulp1 (3), Ulp1(3)(C580S), or the Ulp1(3)(C580S)- 
ASBS (see Fig. 5) were grown to log-phase prior to preparation of yeast cell 
extracts. Individual extracts were then incubated with SUM02 immobilized on 
agarose beads (see material and methods). After washing, bound yeast proteins 
were eluted, separated on SDS-PAGE gels, and analyzed by western blotting 
with an anti GFP antibody. This time, the GFP-tagged Ulp1 (3)(C580S) could be 
detected in the WCE and bound to the SUM02 agarose (Fig. 10D). In contrast, 
neither the wildtype catalytic domain of Ulp1 (Ulp1(3)) nor Ulp1(3)(C580S)ASBS 
bound to SUM02-agarose. Similarly, the Ulp1(3){C580S) could also be purified on 
SUMO-1 agarose (data not shown).
We also analyzed if immobilized Ulp1(3)(C580S) could be used to purify 
SUMO chains. For this experiment, we incubated purified SUM02 chains with
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our immobilized Ulp1(3)(C580S) or the unbound amylose resin. After washing, 
bound SUM02 chains were eluted, separated on SDS-PAGE gels, and analyzed 
by western blotting with an anti- SUM02 antibody. SUM02 chains could clearly 
be detected in the input (Fig. 10E-lane 2) and bound to the MBP-Ulp1(3)(C580S) 
(lane 4), but not the resin-only control (Fig. 10E-lane 3). Both lower and higher 
molecular weight adducts of SUM02 were purified with preference for higher 
molecular weight chains (5-7mers). These data suggest that the Ulp1(3)(C580S) 
can efficiently bind and enrich SUM02 chains in vitro and that the MBP fusion of 
Ulp1 (3)(G580S) may a|So be useful for the purification of sumoylated proteins from 
mammalian cells.
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Figure 10. The Ulp1(3)(C580S) truncation binds SUMO and SUMO-modified 
proteins. (A and B) Immobilized Ulp1(3)(C580S) was analyzed for its ability to 
affinity-purify Smt3 from yeast whole cell extracts (WCE). WCEs containing 
FLAG-tagged-Smt3 (left) or GFP-Smt3 (right) (input) were prepared under non­
denaturing conditions and incubated with immobilized MBP-Ulp1(3)(C580S) 
(3(C580S)), MBP-Ulp1 (3)(C580S) lacking the SUMO-binding surface (3(C580S)ASBS) or 
unbound resin (amylose). After washing and elution, bound Smt3 and Smt3 
conjugates were detected using either anti-Flag or anti-GFP antibodies. (C) 
Immobilized Ulp1(3)(C580S) was analyzed for its ability to affinity-purify Cdc11 from 
yeast WCEs. WCE containing GFP-Smt3 (YOK 1857) was prepared under non­
denaturing conditions and incubated with immobilized MBP-Ulp1(3)(C580S), MBP- 
Ulp1 (3)(C580S) lacking the SUMO-binding surface (3(C580S)ASBS) or unbound resin 
(amylose). After washing and elution, bound Cdc11 was detected using an anti- 
Cdc11 antibody. Arrowhead indicates modified Cdc11. (D) WCEs from 
logarithmically growing yeast cells expressing GFP-tagged Ulp1 (3), 
Ulp1(3)(C580S), Ulp1(3)(C580S)ASBS (input) were prepared under non-denaturing 
conditions. Extracts were then incubated with SUM02 immobilized on agarose 
beads. After washing and elution with sample buffer, bound proteins were 
detected using an anti-GFP antibody. (E) SUM02 chains were incubated with 
resin-bound MBP-Ulp1(3)(C580S) or unbound resin (amylose). After washing and 
elution with sample buffer, bound proteins were detected using an anti-SUM02 
antibody. SUM02 chains loading control (input).
Determination of Ulp1 3<C580S) binding affinity to immobilized SUMO-1
The ability of Ulp1 3(C580S) to bind SUMO and SUMO modified proteins led 
us to further investigate the binding affinity between Ulp1 3(C580S) and SUMO-1. 
Affinity constants of Ulp1 3<C580S) with SUMO-1 were determined using a Biacore 
3000 surface plasmon resonance (SPR) instrument (Affina Biotechnologies, 
Stamford CT) (Fig. 11 A). The equilibrium dissociation constant between Ulp1 
3(C58os) and suMO-1 was determined to be 1.29 x 10'8 M or 12.9 nM (Fig. 11B). 
Previously, it has been demonstrated that the affinity of SIMs for SUMO is in the 
range of 2-3 p.M (Hecker et al 2006). Thus, the interaction between Ulp1 3(C580S)
41
and SUMO-1 is 150-230 times stronger than any previously described SIM and 
SUMO interaction.
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Figure 11. Determination of affinity constants between Ulp1(3)(C580S) and 
SUMO-1. (A) Surface plasmon resonance (SPR) technique was used to study 
the binding kinetics between MBP-Ulp1(3)(C580S) and SUMO-1. Biotinylated 
SUMO-1 was immobilized on research grade streptavidin-coated sensor chips. 
Purified MBP-Ulp1(3)(C580S) was injected as the soluble analyte at a flow rate of 
20 ^il/min in running buffer (see materials and methods). The respective graph 
indicates the interaction between Ulp1 3(C580S) and SUMO-1 at various 
concentrations of MBP-Ulp1(3)(C580S). (B) Affinity constants between MBP- 
Ulp1 (3)(C580S) an(j  biotinylated-SUMO-1 as determined using BIAevaluation 
software. Ka-association rate constant, Kd-dissociation rate constant, KD 
equilibrium dissociation constant
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A SUM02-binding platform for substrate ubiquitylation.
Sumo-targeted ubiquitin ligase proteins (STUbLs) like the yeast Slx5/Slx8 
heterodimer and the human RNF4 protein efficiently ubiquitylate proteins 
modified with SUMO chains (Geoffroy and Hay, 2009; Tatham et al., 2008). 
These proteins interact with their respective sumoylated ubiquitylation targets 
through SIMs. STUbL reactions have been reconstituted in vitro, but the 
purification of target proteins modified with SUMO chains has been both 
technically difficult or prohibitively expensive. The ability of Ulp1(3)(C580S) to 
interact with SUMO may, therefore, provide a simple way to purify a SUMO-chain 
modified STUbL target of choice.
To test if Ulp1 (3)(C580S) can serve as a platform to modify a purified protein 
with SUMO-2 chains, we incubated the immobilized MBP-Ulp1(3)(C580S) with 
SUMO-2 chains and removed unbound SUMO-2 chains by washing with buffer. 
The MBP-Ulp1 (3)(C580S) SUMO-2 chain complex was then eluted and added into 
a STUbL in vitro ubiquitylation reaction containing recombinant RNF4. Proteins 
in the STUbL-mediated ubiquitylation assay were separated on SDS-PAGE gels, 
and analyzed by western blotting with an anti-SUMO antibody. Consistent with 
previous observations, we were able to detect ubiquitylated SUMO-2 chains after 
the STUbL reaction (Fig. 12A). This ubiquitylation was dependent on RNF4 and 
SUM02 chains. Based on these results, we propose that the Ulp1(3)(C580S) may 
provide a useful, widely applicable tool for the study of sumoylated proteins and 
STUbL targets (Fig. 12B).
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Figure 12. MBP-Ulp1(3)(C580S) can serve as a SUM02 binding platform for 
STUbL-mediated substrate ubiquitylation. (A) SUMO-2 chains (Boston 
Biochem) were incubated with resin-bound MBP-Ulp1(3)(C580S). The complex of 
MBP-Ulp1(3)(C580S) with SUMO-2 chains was then eluted and added into an in 
vitro ubiquitylation reaction with the STUbL E3 RNF4. Proteins in the STUbL 
reactions were separated by SDS-PAGE and analyzed by western blotting with 
an anti-SUM02 antibody. Arrows indicate modified SUMO-2 chains. La ne l: no 
SUMO chains; lane 2: no Rnf4; lane 3: no Ulp1(3)(C580S); lane 4: all reagents (B) 
Proposed model for using MBP-Ulp1(3)(C580S) as a SUMO-2 binding platform for 
substrate ubiquitylation. SUMO-2 (spheres labeled S), ubiquitin (spheres labeled 
Ub). RNF4 (gray oval labeled RNF4).
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DISCUSSION:
In this study we demonstrated that region 3 of Ulp1, the catalytic domain, 
contains critical information for the subcellular targeting to sumoylated 
substrates, including the septin Cdc3. To determine how Ulp1 is targeted to its 
substrates, we took advantage of a catalytically inactive Ulp1 mutant (C580S) 
that exhibited a partial redistribution from the nuclear envelope to the bud-neck of 
dividing yeast cells. The re-localization of Ulp1 depended on functional Smt3 and 
sumoylated proteins at the bud-neck of dividing cells.
Importantly, using this novel Ulp1 in vivo septin-ring localization assay, we 
traced the critical targeting information to two features in region 3 of Ulp1, a 
previously identified SUMO-binding surface (SBS) (amino acids 418-447) and a 
SUMO contacting residue (D451) that reside near the carboxy terminus of Smt3 
(see Fig. 5). D451 of Ulp1 has previously been shown to contact Smt3 through a 
salt bridge interaction (lhara et al., 2007; Mossessova and Lima, 2000). 
Therefore, it is possible that perturbation of the D451 salt-bridge results in the 
reduced ability to dock Smt3 in place once it has contacted the SBS domain. 
Indeed, in our analysis, we provide evidence that the salt-bridge forming D451N 
mutation abolishes the targeting of Ulp1 to septins and weakens the interaction of 
the catalytic domain of Ulp1 with Smt3 (Fig 5A and 9).
The sole requirement for the enrichment of full-length Ulp1 at the septin ring 
was the inactivating C580S mutation in the catalytic domain of Ulp1. This finding 
has important implications for the Ulp1-targeting role played by the amino-
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Figure 13. Model. (A) Ulp1 is anchored to the nuclear pore complex (NPC) by 
karyopherins (Kap) including Kap121 and Kap95-Kap60. During mitosis, Ulp1 is 
released from the NPC and allowed access to the cytoplasm. Ulp1 is targeted to 
cytoplasmic substrates (septins) via non-covalent interactions between its 
catalytic domain and SUMO. (B) SUMO is required for proper septin ring 
localization of Ulp1. Yeast mutant strains where sumoylation of the septins is 
abolished no longer have proper Ulp1 localization at the bud-neck.
terminal karyopherin binding domains of Ulp1 (discussed below). Additionally, 
catalysis of Smt3 appears to be required for substrate release. The catalytically 
inactive Ulp1(3)(C580S) mutant is prominently localized to the bud-neck and 
nucleus of dividing yeast cells while the catalytically active wildtype Ulp1(3) 
shows merely a diffuse staining throughout the cell (compare Fig. 5B top). This 
is not due to different stabilities of either protein because both proteins are 
expressed at equivalent levels (see Fig. 10D). We propose, and show in our 
biochemical analysis below, that the C580S mutation may trap a bound Smt3
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protein in place, allowing us to observe it in association with cellular 
desumoylation substrates. In support of this assessment, combining the D451N 
with the C580S mutation abolishes all visible bud-neck localization (Fig. 5A). 
Therefore, we propose that Ulp1(C580S) first targets and docks Smt3 through the 
SBS domain and the salt-bridge forming D451 residue prior to trapping it in place 
due to its inability to cleave after the di-glycine motif of Smt3. We can assume 
that a trapped substrate prevents further catalysis or interactions with other Smt3 
molecules, an assessment that is borne out by our finding that despite its septin- 
targeting and SUMO-binding properties, Ulp1 (3)(C580S) interacts only weakly with 
Smt3 in a two-hybrid assay (Fig. 9). A better understanding of how the 
sumoylated substrate is trapped by Ulp1(3)(C580S) may have important 
implications for the rational design of inhibitors for Ulp1 -like SUMO proteases but 
may have to wait for elucidation of the co-crystal structure with a trapped 
substrate.
The interaction of budding yeast Ulp1 with Smt3 relies on multiple 
hydrophobic and salt bridge interactions between the catalytic domain (region 3) 
of Ulp1 and the carboxy-terminal extension of Smt3. Making multiple interactions 
with Smt3, Ulp1 is particularly well suited to interact with a wide variety of 
sumoylated substrates (Mossessova and Lima, 2000; Mukhopadhyay and 
Dasso, 2007). Other SUMO proteases, Ulp2 and several SENP proteins 
(Senpl ,2,6,7), are believed to interact non-covalently with their sumoylated 
substrates through dedicated SIMs (Kroetz et al., 2009; Mukhopadhyay and
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Dasso, 2007). From our structure-function analysis of region 3, Ulp1 seems to 
employ a unique mode of interaction with Smt3 and sumoylated substrates. Ulp1 
does not appear to contain bona fide canonical SIMs and neither of the amino- 
terminal domains of Ulp1 (region 1 and 2) interact with Smt3 or become enriched 
at the septin ring. This assessment is also underscored by the arrangement of 
Smt3 and Ulp1 in the co-crystal structure (Mossessova and Lima, 2000). The 
hydrophobic groove of Smt3 that would interact with a SIM-containing protein is 
turned away from the domains of Ulp1 that interact with Smt3. Interestingly, this 
may suggest that Ulp1 can be recruited to proteins that are covalently or non- 
covalently modified with SUMO and SUMO chains.
Our research demonstrates for the first time that non-covalent interactions 
between Ulp1 and SUMO are not only important for SUMO binding, but also for 
the cytosolic targeting of this SUMO protease to the bud-neck and potentially 
sumoylated septins (Fig. 13). Septins are not the only cytosolic substrates of 
Ulp1, but arguably the most prevalent (Johnson and Blobel, 1999; Takahashi et 
al., 2000) and, therefore, may be readily scored in our bud-neck targeting assay 
(Fig. 5A and 5B). We predict that Ulp1 is also targeted to other cytosolic and 
septin bound sumoylated substrate proteins, for example the karyogamy protein 
Kar9 (Leisner et al., 2008). However, due to the low local concentrations in 
comparison to sumoylated septins, these proteins may be hard to detect. We 
propose, however, that sumoylated proteins that accumulate or aggregate in the 
cytosol of yeast cells may be readily detectable by Ulp1(3)(C580S). As detailed
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below, Ulp1(3)(C580S) also provides a useful tool to purify these sumoylated 
proteins (Fig. 10) and these studies are underway (Kerscher and Elmore, 
unpublished results). In conclusion, our findings provide strong evidence that 
SUMO, at least in the case of sumoylated proteins at the septin ring, is a required 
signal for the cytoplasmic targeting of Ulp1. Our alignments of the SBS domain 
and the juxtaposed salt-bridge forming D451 residue reveals that this mode of 
targeting may also be conserved in other metazoan Ulp1 -like SUMO-proteases 
(Fig. 7 A and 7B).
Though we clearly show that Ulp1 becomes enriched at the bud-neck, we 
do not yet fully understand how Ulp1 arrives at this subcellular localization. Our 
findings support the previous observation that Kap121 plays an important role in 
promoting Ulp1 targeting to the septin ring. Similar to a previously described 
Ulp1 mutant that lacks the Kap60/Kap95 binding domain (region 2) (Makhnevych 
et al., 2007), the septin ring localization of the full-length Ulp1(C580S) protein 
described here is dependent on functional Kap121. It is unlikely that the 
association with Kap121 shuttles Ulp1 to the septins. Rather, as previously 
reported, in mitosis Kap121 becomes associated with a transport inhibitory 
nucleoporin, Nup53, and may thus exclude Ulp1 access to the inner phase of the 
nuclear pore complex (Makhnevych et al., 2003). This suggests that in the 
absence of Kap121-binding, a fraction of Ulp1 is free to associate with 
sumoylated septins. Our studies confirm that Ulp1 lacking the Kap60/Kap95 
binding domain (region 2) are enriched at the NPC and the septin ring (Fig. 5A).
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We extend these observations by showing that the ability to target sumoylated 
septins resides in the catalytic domain (region 3) of Ulp1 (Fig. 5B). We find that a 
Ulp1 (3)(C580S) mutant, but not wildtype Ulp1(3), is enriched at the septin ring in the 
absence of Kap121.
Taken together, these data suggest that both the Ulp1 (3)(C580S) mutant and 
WT Ulp1 (3) can interact with sumoylated septins but, unlike the subtrate-trapping 
Ulp1(3)(C580S) mutant, the catalytically active WT Ulp1(3) may be quickly released 
after desumoylation of the target protein giving it a diffuse appearance in the cell. 
How Kap121 helps Ulp1-A2 to be retained at the septin ring in the absence of the 
C580S mutation is currently not clear. Kap121 may theoretically promote the 
interaction with a bud-neck-localized protein. However, the localization of 
Kap121 to septins has not previously been reported.
One intriguing aspect of our study is the analysis of the substrate-trapping 
Ulp1(3)(C580S) construct. Detailed binding studies on the avidity of the 
Ulp1 (3)(C580S) protein with Smt3 are currently underway but three lines of evidence 
reveal the avid interaction of Ulp1(3)(C580S) with SUMO proteins and sumoylated 
substrates. First, this Ulp1-derived construct shows a pronounced interaction 
with the bud-neck comprised of sumoylated septins in vivo. Second, the reduced 
interaction of Ulp1(3)(C580S) with Smt3 in a two-hybrid assay can be re-established 
by introduction of mutations that weaken the interaction with Smt3. And third, the 
purified, recombinant Ulp1(3)(C580S) protein is a potent affinity-tag for the 
purification of Smt3 conjugates and SUMO-modified proteins. A related study
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involving the C603S mutant of the human SENP1 protease confirms our 
assessment of the substrate-trapping feature. The authors observe re­
localization of their SENP1(C603S) mutant in vivo to promyelocytic leukemia 
(PML) nuclear bodies and domains of the HDAC4 protein, suggesting that 
SUMO-dependent-targeting may be a conserved feature of Ulp1 -like SUMO 
proteases (Bailey and O'hare, 2004). The latter may also provide a useful 
strategy for the identification of mitotically important desumoylation substrates. 
Indeed, two-hybrid screens with Ulp1(3)(C580S) in the lab have already identified 
several novel cytosolic desumoylation targets (Donaher and Kerscher 
unpublished observations). Finally, we are also exploring the ability of 
Ulp1 (3)(C580S) to act as a SUMO-chain binding-tag that can be used to promote 
the interaction of putative STUbL target proteins with RNF4 and other STUbLs 
(Fig. 12).
Flow Ulp1 and other SUMO proteases target specific mitotic substrates for 
desumoylation remains unknown. Our analysis of SUMO-dependent Ulp1- 
targeting to the septin ring provides important evidence that Ulp1 -like SUMO 
proteases do not passively await their desumoylation substrates but rather 
dynamically localize to them in a cell cycle specific manner. Future experiments 
that take advantage of the SUMO-binding properties of the substrate-trapping 
Ulp1 (3)(C580S) construct may prove useful for the identification of clinically relevant 
targets of conserved Ulp1 -like SUMO proteases in yeast and human cells.
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